Method for estimating creatinine clearance using measurements of body cell mass
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 3, 1998
Grant Date -
N/A
app pub date -
Aug 13, 1996
filing date -
Aug 13, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Creatinine clearance is estimated in a patient by determining his or her body cell mass. In turn, the body cell mass of the patient is measured using bioimpedance analysis techniques. The determined value of body cell mass is normalized by the height.sup.2 of the patient. The body cell mass or its normalized value provides an indication of actual creatinine clearance in the subject through use of a predictive formula. From this prediction, accurate dosages of potentially nephrotoxic medications can be appropriately prescribed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully